汇总不同安全数据源:主动收集与自发报告合并对药物警戒信号检测的影响
该研究通过模拟安全数据库,评估将主动收集的不良事件报告与自发报告合并后进行不相称性分析的影响。结果发现,在事件发生率不变时增加主动收集病例量会降低不相称性评分的变异性,减少或消除信号;同时变化病例量和报告率可能掩盖真实信号或错误识别信号。提示安全数据量增加不一定改善信号检测。
要点
- 主动收集与自发报告合并可降低不相称性评分变异性,减少信号检出。
- 病例量和报告率同时变化可能掩盖真实信号或产生假阳性。
- 安全数据量增加不必然提高信号检测能力。
核心结论
- 模拟数据表明,将主动收集的不良事件数据与自发报告数据合并可能影响不相称性分析结果,掩盖真实安全信号并识别假阳性。
研究设计与样本
- 研究采用模拟安全数据库,评估两种条件下假设药物的不相称性评分:条件一保持事件发生恒定并改变主动收集病例量;条件二同时改变事件发生比例和主动收集病例量。
主要发现
- 在条件一中,所有不良事件术语在任何药物下发生概率相同,增加主动收集病例量并保持事件发生恒定导致不相称性评分变异性降低,从而减少或消除已识别的不相称报告信号。
- 在条件二中,同时改变病例量和报告率可能掩盖真实安全信号,并在无信号处错误识别信号。
临床怎么用
- 临床药学智能体在解读不相称性分析结果时,应关注数据来源合并对信号检测的影响,避免仅凭数据量增加判断信号可靠性。
局限性
- 研究基于模拟数据,结论需在真实世界数据中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The volume of adverse events (AEs) collected, analysed, and reported has been increasing at a rapid rate for over the past 10 years, largely due to the growth of solicited programmes. The proportion of various forms of solicited case data has evolved over time, with the main relative volume increase coming from Patient Support Programmes. In this study, we sought to examine the impact of the pooling of AE report data from solicited sources with data from spontaneous sources to safety signal detection using disproportionality analysis methods. METHODS: Two conditions were explored in which disproportionality scores from hypothetical drugs were evaluated in a simulated safety database. The first condition held occurrence of events constant and varied solicited case volume, while the second condition varied both proportion of occurrence of events and solicited case volume. RESULTS: In the first setting, where all AE terms have the same probability to occur with any drug, increasing volumes of solicited cases while keeping occurrence of events constant leads to reduced variability in disproportionality scores, consequently reducing or eliminating identified signals of disproportionate reporting. In the second setting, varying both case volume and reporting rates can mask true safety signals and falsely identify signals where there are none. CONCLUSIONS: This analysis of simulated data suggests that pooling AE data from solicited sources with spontaneous case data may impact the results of disproportionality analyses, masking true safety signals and identifying false positives. Therefore, increased volumes of safety data do not necessarily correlate with improved safety signal detection.
引用
- Jokinen JD, Walley RJ, Colopy MW, et al. Pooling Different Safety Data Sources: Impact of Combining Solicited and Spontaneous Reports on Signal Detection In Pharmacovigilance. Drug Saf. 2019. PMID: 31190237. doi:10.1007/s40264-019-00843-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。